Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic Cancer: A Retrospective Cohort Study

Background: Epidemiologic studies have produced conflicting results on the effects of metformin on pancreatic cancer. This study aimed to observe and analyze whether metformin use is associated with better prognosis in pancreatic cancer. Materials and Methods: In this retrospective cohort study, all...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Qian, Fang-jing, Ye, Zhi-qiang, Xie, Wen-xia, He, You-di, Huang, Jing-ren, Tian, Ling, Gu, Dian-na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806383/
https://www.ncbi.nlm.nih.gov/pubmed/36583563
http://dx.doi.org/10.1177/15330338221138208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806383/
https://www.ncbi.nlm.nih.gov/pubmed/36583563
http://dx.doi.org/10.1177/15330338221138208

Ejemplares similares